To determine whether the two MDS groups’ immunophenotypic HSPC architectures were the result of distinct differentiation potentials of the early HSCs or of the aberrant expression of cell surface markers, we analyzed the gene expression profile of the lineage-negative (Lin−) CD34+ HSPC compartment at the single-cell level. The gene discussed is PSMA7; the disease is myelodysplastic syndrome.